nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—ADORA1—Aminophylline—chronic obstructive pulmonary disease	0.65	1	CbGbCtD
Gabapentin—CACNA1B—respiratory system—chronic obstructive pulmonary disease	0.00591	0.171	CbGeAlD
Gabapentin—CACNA1B—connective tissue—chronic obstructive pulmonary disease	0.0052	0.151	CbGeAlD
Gabapentin—BCAT1—respiratory system—chronic obstructive pulmonary disease	0.00465	0.135	CbGeAlD
Gabapentin—CACNA2D2—respiratory system—chronic obstructive pulmonary disease	0.00426	0.123	CbGeAlD
Gabapentin—BCAT1—trachea—chronic obstructive pulmonary disease	0.00344	0.0995	CbGeAlD
Gabapentin—CACNA1B—lung—chronic obstructive pulmonary disease	0.00314	0.0909	CbGeAlD
Gabapentin—BCAT1—lung—chronic obstructive pulmonary disease	0.00247	0.0715	CbGeAlD
Gabapentin—CACNA2D2—lung—chronic obstructive pulmonary disease	0.00226	0.0656	CbGeAlD
Gabapentin—CACNA2D1—lung—chronic obstructive pulmonary disease	0.00163	0.0471	CbGeAlD
Gabapentin—ADORA1—lung—chronic obstructive pulmonary disease	0.00157	0.0455	CbGeAlD
Gabapentin—BCAT1—Amino acid and derivative metabolism—APIP—chronic obstructive pulmonary disease	0.00115	0.0872	CbGpPWpGaD
Gabapentin—CACNA1B—Synaptic Vesicle Pathway—SLC6A4—chronic obstructive pulmonary disease	0.000963	0.0733	CbGpPWpGaD
Gabapentin—CACNA2D2—Regulation of insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.000939	0.0715	CbGpPWpGaD
Gabapentin—CACNA2D2—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000738	0.0562	CbGpPWpGaD
Gabapentin—BCAT1—Amino acid and derivative metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000686	0.0523	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000533	0.0405	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000434	0.0331	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000408	0.0311	CbGpPWpGaD
Gabapentin—BCAT1—Amino acid and derivative metabolism—GCLC—chronic obstructive pulmonary disease	0.000399	0.0304	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000353	0.0269	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000333	0.0253	CbGpPWpGaD
Gabapentin—CACNA1B—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.00032	0.0244	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000288	0.0219	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00027	0.0206	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—MMP9—chronic obstructive pulmonary disease	0.000254	0.0194	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00022	0.0168	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APIP—chronic obstructive pulmonary disease	0.00021	0.016	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—TP53—chronic obstructive pulmonary disease	0.000172	0.0131	CbGpPWpGaD
Gabapentin—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000561	CcSEcCtD
Gabapentin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000169	0.000558	CcSEcCtD
Gabapentin—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000555	CcSEcCtD
Gabapentin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.000553	CcSEcCtD
Gabapentin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.000553	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000167	0.0127	CbGpPWpGaD
Gabapentin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00055	CcSEcCtD
Gabapentin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000166	0.000548	CcSEcCtD
Gabapentin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000166	0.000548	CcSEcCtD
Gabapentin—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000547	CcSEcCtD
Gabapentin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000165	0.000545	CcSEcCtD
Gabapentin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.000544	CcSEcCtD
Gabapentin—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.000544	CcSEcCtD
Gabapentin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.000543	CcSEcCtD
Gabapentin—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000542	CcSEcCtD
Gabapentin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00054	CcSEcCtD
Gabapentin—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000163	0.00054	CcSEcCtD
Gabapentin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.000538	CcSEcCtD
Gabapentin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000162	0.000535	CcSEcCtD
Gabapentin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.000535	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000162	0.000534	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.000534	CcSEcCtD
Gabapentin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.00053	CcSEcCtD
Gabapentin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000161	0.00053	CcSEcCtD
Gabapentin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.000528	CcSEcCtD
Gabapentin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00016	0.000527	CcSEcCtD
Gabapentin—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000159	0.000525	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000158	0.000523	CcSEcCtD
Gabapentin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.000523	CcSEcCtD
Gabapentin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000158	0.000523	CcSEcCtD
Gabapentin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.000521	CcSEcCtD
Gabapentin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000158	0.000521	CcSEcCtD
Gabapentin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000157	0.000519	CcSEcCtD
Gabapentin—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000517	CcSEcCtD
Gabapentin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.000517	CcSEcCtD
Gabapentin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000156	0.000516	CcSEcCtD
Gabapentin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.000516	CcSEcCtD
Gabapentin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000156	0.000515	CcSEcCtD
Gabapentin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000156	0.000514	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000155	0.0118	CbGpPWpGaD
Gabapentin—Injury—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000511	CcSEcCtD
Gabapentin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000155	0.00051	CcSEcCtD
Gabapentin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000154	0.000509	CcSEcCtD
Gabapentin—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.000508	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000153	0.000506	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.000506	CcSEcCtD
Gabapentin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000153	0.000505	CcSEcCtD
Gabapentin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.000505	CcSEcCtD
Gabapentin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000153	0.000505	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.000504	CcSEcCtD
Gabapentin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000152	0.000501	CcSEcCtD
Gabapentin—Pain—Formoterol—chronic obstructive pulmonary disease	0.000152	0.000501	CcSEcCtD
Gabapentin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.000501	CcSEcCtD
Gabapentin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.000501	CcSEcCtD
Gabapentin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.000501	CcSEcCtD
Gabapentin—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000499	CcSEcCtD
Gabapentin—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000499	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.000151	0.0115	CbGpPWpGaD
Gabapentin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.000497	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00015	0.000496	CcSEcCtD
Gabapentin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00015	0.000495	CcSEcCtD
Gabapentin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000493	CcSEcCtD
Gabapentin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000492	CcSEcCtD
Gabapentin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000149	0.000491	CcSEcCtD
Gabapentin—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.000491	CcSEcCtD
Gabapentin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000148	0.00049	CcSEcCtD
Gabapentin—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.000488	CcSEcCtD
Gabapentin—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.000488	CcSEcCtD
Gabapentin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.000487	CcSEcCtD
Gabapentin—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000487	CcSEcCtD
Gabapentin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000147	0.000486	CcSEcCtD
Gabapentin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000147	0.000485	CcSEcCtD
Gabapentin—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000146	0.000484	CcSEcCtD
Gabapentin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.000483	CcSEcCtD
Gabapentin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000146	0.000483	CcSEcCtD
Gabapentin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000146	0.000482	CcSEcCtD
Gabapentin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.000481	CcSEcCtD
Gabapentin—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000481	CcSEcCtD
Gabapentin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000145	0.00048	CcSEcCtD
Gabapentin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000145	0.000479	CcSEcCtD
Gabapentin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000145	0.000479	CcSEcCtD
Gabapentin—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000479	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.000478	CcSEcCtD
Gabapentin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.000477	CcSEcCtD
Gabapentin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.000473	CcSEcCtD
Gabapentin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.000473	CcSEcCtD
Gabapentin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000142	0.000469	CcSEcCtD
Gabapentin—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000469	CcSEcCtD
Gabapentin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000141	0.000466	CcSEcCtD
Gabapentin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.000466	CcSEcCtD
Gabapentin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00014	0.000463	CcSEcCtD
Gabapentin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.000463	CcSEcCtD
Gabapentin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.000463	CcSEcCtD
Gabapentin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00014	0.000463	CcSEcCtD
Gabapentin—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000462	CcSEcCtD
Gabapentin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00014	0.000462	CcSEcCtD
Gabapentin—BCAT1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000139	0.0106	CbGpPWpGaD
Gabapentin—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000458	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000139	0.0106	CbGpPWpGaD
Gabapentin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000139	0.000458	CcSEcCtD
Gabapentin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000139	0.000457	CcSEcCtD
Gabapentin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000139	0.000457	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000138	0.0105	CbGpPWpGaD
Gabapentin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000138	0.000456	CcSEcCtD
Gabapentin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.000456	CcSEcCtD
Gabapentin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000138	0.000455	CcSEcCtD
Gabapentin—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.000455	CcSEcCtD
Gabapentin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000137	0.000454	CcSEcCtD
Gabapentin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000137	0.000454	CcSEcCtD
Gabapentin—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000453	CcSEcCtD
Gabapentin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.000453	CcSEcCtD
Gabapentin—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000448	CcSEcCtD
Gabapentin—BCAT1—Metabolism—GC—chronic obstructive pulmonary disease	0.000136	0.0103	CbGpPWpGaD
Gabapentin—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.000447	CcSEcCtD
Gabapentin—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000446	CcSEcCtD
Gabapentin—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000445	CcSEcCtD
Gabapentin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.00044	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000133	0.0101	CbGpPWpGaD
Gabapentin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.000437	CcSEcCtD
Gabapentin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.000437	CcSEcCtD
Gabapentin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000131	0.000432	CcSEcCtD
Gabapentin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000131	0.000432	CcSEcCtD
Gabapentin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000131	0.000431	CcSEcCtD
Gabapentin—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.000431	CcSEcCtD
Gabapentin—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00043	CcSEcCtD
Gabapentin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000128	0.000423	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000127	0.00971	CbGpPWpGaD
Gabapentin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.000421	CcSEcCtD
Gabapentin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000127	0.000421	CcSEcCtD
Gabapentin—BCAT1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000126	0.0096	CbGpPWpGaD
Gabapentin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000126	0.000415	CcSEcCtD
Gabapentin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.000415	CcSEcCtD
Gabapentin—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000414	CcSEcCtD
Gabapentin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000125	0.000412	CcSEcCtD
Gabapentin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.000408	CcSEcCtD
Gabapentin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000123	0.000406	CcSEcCtD
Gabapentin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000121	0.000401	CcSEcCtD
Gabapentin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.000401	CcSEcCtD
Gabapentin—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000398	CcSEcCtD
Gabapentin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.000397	CcSEcCtD
Gabapentin—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000395	CcSEcCtD
Gabapentin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000119	0.000393	CcSEcCtD
Gabapentin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.000392	CcSEcCtD
Gabapentin—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000389	CcSEcCtD
Gabapentin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000117	0.000388	CcSEcCtD
Gabapentin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000117	0.000388	CcSEcCtD
Gabapentin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000115	0.00038	CcSEcCtD
Gabapentin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.000379	CcSEcCtD
Gabapentin—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000374	CcSEcCtD
Gabapentin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000113	0.000373	CcSEcCtD
Gabapentin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.000373	CcSEcCtD
Gabapentin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.00037	CcSEcCtD
Gabapentin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000112	0.00037	CcSEcCtD
Gabapentin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000112	0.000369	CcSEcCtD
Gabapentin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.000369	CcSEcCtD
Gabapentin—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000369	CcSEcCtD
Gabapentin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.000367	CcSEcCtD
Gabapentin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000111	0.000367	CcSEcCtD
Gabapentin—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000367	CcSEcCtD
Gabapentin—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000367	CcSEcCtD
Gabapentin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000366	CcSEcCtD
Gabapentin—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000366	CcSEcCtD
Gabapentin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000111	0.000365	CcSEcCtD
Gabapentin—Rash—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000362	CcSEcCtD
Gabapentin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000109	0.000362	CcSEcCtD
Gabapentin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000361	CcSEcCtD
Gabapentin—Depression—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000361	CcSEcCtD
Gabapentin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000109	0.00036	CcSEcCtD
Gabapentin—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000357	CcSEcCtD
Gabapentin—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000355	CcSEcCtD
Gabapentin—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000354	CcSEcCtD
Gabapentin—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000354	CcSEcCtD
Gabapentin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000352	CcSEcCtD
Gabapentin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000351	CcSEcCtD
Gabapentin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000349	CcSEcCtD
Gabapentin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000349	CcSEcCtD
Gabapentin—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000349	CcSEcCtD
Gabapentin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000349	CcSEcCtD
Gabapentin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000105	0.000348	CcSEcCtD
Gabapentin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000105	0.000348	CcSEcCtD
Gabapentin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.000347	CcSEcCtD
Gabapentin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000342	CcSEcCtD
Gabapentin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000103	0.000341	CcSEcCtD
Gabapentin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000337	CcSEcCtD
Gabapentin—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000336	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000101	0.00769	CbGpPWpGaD
Gabapentin—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000331	CcSEcCtD
Gabapentin—Nausea—Salbutamol—chronic obstructive pulmonary disease	9.95e-05	0.000329	CcSEcCtD
Gabapentin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	9.91e-05	0.000327	CcSEcCtD
Gabapentin—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	9.83e-05	0.000325	CcSEcCtD
Gabapentin—Hallucination—Prednisone—chronic obstructive pulmonary disease	9.78e-05	0.000323	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	9.71e-05	0.00739	CbGpPWpGaD
Gabapentin—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	9.66e-05	0.000319	CcSEcCtD
Gabapentin—Oedema—Prednisolone—chronic obstructive pulmonary disease	9.61e-05	0.000317	CcSEcCtD
Gabapentin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	9.61e-05	0.000317	CcSEcCtD
Gabapentin—Shock—Prednisolone—chronic obstructive pulmonary disease	9.46e-05	0.000312	CcSEcCtD
Gabapentin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	9.38e-05	0.00031	CcSEcCtD
Gabapentin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	9.29e-05	0.000307	CcSEcCtD
Gabapentin—Eye disorder—Prednisone—chronic obstructive pulmonary disease	9.19e-05	0.000303	CcSEcCtD
Gabapentin—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	8.88e-05	0.000293	CcSEcCtD
Gabapentin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	8.69e-05	0.000287	CcSEcCtD
Gabapentin—Alopecia—Prednisone—chronic obstructive pulmonary disease	8.69e-05	0.000287	CcSEcCtD
Gabapentin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	8.63e-05	0.000285	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	8.61e-05	0.00656	CbGpPWpGaD
Gabapentin—Mental disorder—Prednisone—chronic obstructive pulmonary disease	8.61e-05	0.000284	CcSEcCtD
Gabapentin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	8.56e-05	0.000283	CcSEcCtD
Gabapentin—Erythema—Prednisone—chronic obstructive pulmonary disease	8.56e-05	0.000283	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.44e-05	0.00643	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	8.32e-05	0.00633	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	8.27e-05	0.0063	CbGpPWpGaD
Gabapentin—Pain—Prednisolone—chronic obstructive pulmonary disease	8.22e-05	0.000271	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—GC—chronic obstructive pulmonary disease	8.21e-05	0.00625	CbGpPWpGaD
Gabapentin—Vision blurred—Prednisone—chronic obstructive pulmonary disease	8.06e-05	0.000266	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	8.03e-05	0.00611	CbGpPWpGaD
Gabapentin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	7.94e-05	0.000262	CcSEcCtD
Gabapentin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	7.92e-05	0.000262	CcSEcCtD
Gabapentin—Anaemia—Prednisone—chronic obstructive pulmonary disease	7.91e-05	0.000261	CcSEcCtD
Gabapentin—Agitation—Prednisone—chronic obstructive pulmonary disease	7.86e-05	0.00026	CcSEcCtD
Gabapentin—Angioedema—Prednisone—chronic obstructive pulmonary disease	7.82e-05	0.000258	CcSEcCtD
Gabapentin—Malaise—Prednisone—chronic obstructive pulmonary disease	7.72e-05	0.000255	CcSEcCtD
Gabapentin—Vertigo—Prednisone—chronic obstructive pulmonary disease	7.69e-05	0.000254	CcSEcCtD
Gabapentin—Syncope—Prednisone—chronic obstructive pulmonary disease	7.67e-05	0.000253	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.64e-05	0.00581	CbGpPWpGaD
Gabapentin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	7.63e-05	0.000252	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	7.59e-05	0.00578	CbGpPWpGaD
Gabapentin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	7.52e-05	0.000248	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	7.43e-05	0.00566	CbGpPWpGaD
Gabapentin—Convulsion—Prednisone—chronic obstructive pulmonary disease	7.41e-05	0.000245	CcSEcCtD
Gabapentin—BCAT1—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.41e-05	0.00564	CbGpPWpGaD
Gabapentin—Hypertension—Prednisone—chronic obstructive pulmonary disease	7.39e-05	0.000244	CcSEcCtD
Gabapentin—BCAT1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.32e-05	0.00557	CbGpPWpGaD
Gabapentin—Myalgia—Prednisone—chronic obstructive pulmonary disease	7.29e-05	0.000241	CcSEcCtD
Gabapentin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	7.29e-05	0.000241	CcSEcCtD
Gabapentin—Anxiety—Prednisone—chronic obstructive pulmonary disease	7.26e-05	0.00024	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	7.24e-05	0.000239	CcSEcCtD
Gabapentin—Discomfort—Prednisone—chronic obstructive pulmonary disease	7.2e-05	0.000238	CcSEcCtD
Gabapentin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.08e-05	0.000234	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	7.08e-05	0.00539	CbGpPWpGaD
Gabapentin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	6.98e-05	0.000231	CcSEcCtD
Gabapentin—Oedema—Prednisone—chronic obstructive pulmonary disease	6.98e-05	0.000231	CcSEcCtD
Gabapentin—Infection—Prednisone—chronic obstructive pulmonary disease	6.94e-05	0.000229	CcSEcCtD
Gabapentin—Shock—Prednisone—chronic obstructive pulmonary disease	6.87e-05	0.000227	CcSEcCtD
Gabapentin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	6.85e-05	0.000226	CcSEcCtD
Gabapentin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	6.82e-05	0.000225	CcSEcCtD
Gabapentin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	6.78e-05	0.000224	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	6.76e-05	0.00515	CbGpPWpGaD
Gabapentin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	6.75e-05	0.000223	CcSEcCtD
Gabapentin—BCAT1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.68e-05	0.00509	CbGpPWpGaD
Gabapentin—Anorexia—Prednisone—chronic obstructive pulmonary disease	6.66e-05	0.00022	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	6.5e-05	0.00495	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	6.43e-05	0.00489	CbGpPWpGaD
Gabapentin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.36e-05	0.00021	CcSEcCtD
Gabapentin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.36e-05	0.00021	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	6.33e-05	0.00482	CbGpPWpGaD
Gabapentin—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.32e-05	0.000209	CcSEcCtD
Gabapentin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.27e-05	0.000207	CcSEcCtD
Gabapentin—BCAT1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.16e-05	0.00469	CbGpPWpGaD
Gabapentin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.15e-05	0.000203	CcSEcCtD
Gabapentin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.07e-05	0.000201	CcSEcCtD
Gabapentin—Rash—Prednisolone—chronic obstructive pulmonary disease	6.06e-05	0.0002	CcSEcCtD
Gabapentin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.05e-05	0.0002	CcSEcCtD
Gabapentin—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.02e-05	0.000199	CcSEcCtD
Gabapentin—Headache—Prednisolone—chronic obstructive pulmonary disease	6.02e-05	0.000199	CcSEcCtD
Gabapentin—Constipation—Prednisone—chronic obstructive pulmonary disease	5.97e-05	0.000197	CcSEcCtD
Gabapentin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.76e-05	0.00019	CcSEcCtD
Gabapentin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.71e-05	0.000189	CcSEcCtD
Gabapentin—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.71e-05	0.000189	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	5.71e-05	0.00434	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	5.66e-05	0.00431	CbGpPWpGaD
Gabapentin—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.55e-05	0.000183	CcSEcCtD
Gabapentin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.52e-05	0.000182	CcSEcCtD
Gabapentin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.52e-05	0.000182	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	5.18e-05	0.00395	CbGpPWpGaD
Gabapentin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.15e-05	0.00017	CcSEcCtD
Gabapentin—BCAT1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.13e-05	0.00391	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.06e-05	0.00386	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	5.05e-05	0.00385	CbGpPWpGaD
Gabapentin—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.01e-05	0.000165	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	5.01e-05	0.00382	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	4.95e-05	0.00377	CbGpPWpGaD
Gabapentin—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.94e-05	0.000163	CcSEcCtD
Gabapentin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.78e-05	0.000158	CcSEcCtD
Gabapentin—BCAT1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.72e-05	0.00359	CbGpPWpGaD
Gabapentin—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.62e-05	0.000153	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.49e-05	0.00342	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.47e-05	0.00341	CbGpPWpGaD
Gabapentin—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.44e-05	0.000147	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—GCLC—chronic obstructive pulmonary disease	4.44e-05	0.00338	CbGpPWpGaD
Gabapentin—Rash—Prednisone—chronic obstructive pulmonary disease	4.4e-05	0.000145	CcSEcCtD
Gabapentin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.4e-05	0.000145	CcSEcCtD
Gabapentin—Headache—Prednisone—chronic obstructive pulmonary disease	4.38e-05	0.000144	CcSEcCtD
Gabapentin—Nausea—Prednisone—chronic obstructive pulmonary disease	4.15e-05	0.000137	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.05e-05	0.00308	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	4.02e-05	0.00306	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.8e-05	0.00289	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.73e-05	0.00284	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.58e-05	0.00273	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	3.51e-05	0.00268	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.25e-05	0.00248	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	3.22e-05	0.00245	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.2e-05	0.00244	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.11e-05	0.00237	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.07e-05	0.00234	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.06e-05	0.00233	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.06e-05	0.00233	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ALB—chronic obstructive pulmonary disease	3.04e-05	0.00231	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.91e-05	0.00221	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.9e-05	0.00221	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.86e-05	0.00218	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.8e-05	0.00213	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.71e-05	0.00206	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.54e-05	0.00193	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.24e-05	0.0017	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.08e-05	0.00158	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.92e-05	0.00146	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ALB—chronic obstructive pulmonary disease	1.84e-05	0.0014	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.76e-05	0.00134	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.73e-05	0.00132	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.72e-05	0.00131	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.57e-05	0.0012	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.56e-05	0.00119	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.5e-05	0.00114	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.4e-05	0.00106	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.15e-05	0.000874	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.1e-05	0.000834	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.05e-05	0.000796	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.27e-06	0.000706	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.82e-06	0.000671	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.39e-06	0.000639	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.53e-06	0.000574	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.91e-06	0.000526	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.78e-06	0.000516	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.69e-06	0.000433	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.21e-06	0.000397	CbGpPWpGaD
